Also known as Banzel
Rufinamide is an anticonvulsant medication. It is used in combination with other medication and therapy to treat Lennox–Gastaut syndrome and various other seizure disorders. Rufinamide, a triazole derivative, was developed in 2004 by Novartis Pharma, AG, and is manufactured by Eisai.Source: Wikipedia
Estimated Total Cost: $705.76 for an average of 28 days supply
Patients are most commonly prescribed rufinamide to treat epilepsy, seizures, blastomycosis, and rabies.
Patients taking rufinamide most commonly experience side effects like headache, fatigue, and vomiting.